Prof. Drayson was recruited to the University of Birmingham in 1990 as a Clinical Lecturer in Immunology, and subsequently obtained Membership of the Royal College of Pathologists in 1993. Since 2000, he has been Director of the Clinical Immunology Service (CIS), one of the leading medical services in immuno-diagnostics in the UK. CIS provides a link between the University of Birmingham and the clinical areas for application in clinical academia and NHS practice. He has played a key role in developing and demonstrating the utility of the first clinical test for serum immunoglobulin Free Light Chains (FLC). This test was disseminated worldwide via a UoB spinout company Binding Site and has been incorporated into international guidelines for diagnosis and management of all Plasma Cell Dyscrasias. Prof. Drayson’s research program is supported by major grants from Cancer Research UK, Leukemia and Lymphoma Research, the Medical Research Council, and the National Institute of Health Research.
